There was a clear trend, with most studies pointing toward differences in beta diversity between patients with IBD and controls ( Figure S1 ).
← all excerpts
Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies.
1
—
—